Cargando…
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
BACKGROUND: IDH-mutant glioblastoma is classified by the 2016 CNS WHO as a group with good prognosis. However, the actual number of cases examined in the literature is relatively small. We hypothesize that IDH-mutant glioblastoma is not a uniform group and should be further stratified. METHODS: We c...
Autores principales: | Li, Kay Ka-Wai, Shi, Zhi-Feng, Malta, Tathiane M, Chan, Aden Ka-Yin, Cheng, Shaz, Kwan, Johnny Sheung Him, Yang, Rui Ryan, Poon, Wai Sang, Mao, Ying, Noushmehr, Houtan, Chen, Hong, Ng, Ho-Keung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798792/ https://www.ncbi.nlm.nih.gov/pubmed/31667475 http://dx.doi.org/10.1093/noajnl/vdz015 |
Ejemplares similares
-
Molecular landscape of
IDH
‐wild type, pTERT
‐wild type adult glioblastomas
por: Liu, Emma Munan, et al.
Publicado: (2022) -
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020) -
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
por: Herrgott, Grayson A, et al.
Publicado: (2022) -
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)